On Friday, MBX Biosciences Inc (NASDAQ: MBX) was 11.82% up from the session before settling in for the closing price of $13.03. A 52-week range for MBX has been $4.81 – $27.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 51.98%. With a float of $14.85 million, this company’s outstanding shares have now reached $33.42 million.
Let’s look at the performance matrix of the company that is accounted for 43 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
MBX Biosciences Inc (MBX) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward MBX Biosciences Inc stocks. The insider ownership of MBX Biosciences Inc is 55.58%, while institutional ownership is 54.15%. The most recent insider transaction that took place on Apr 08 ’25, was worth 45,312. In this transaction Director of this company bought 7,693 shares at a rate of $5.89, taking the stock ownership to the 24,329 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Director bought 143,170 for $10.84, making the entire transaction worth $1,551,963. This insider now owns 3,255,000 shares in total.
MBX Biosciences Inc (MBX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.98% per share during the next fiscal year.
MBX Biosciences Inc (NASDAQ: MBX) Trading Performance Indicators
You can see what MBX Biosciences Inc (MBX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 23.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.20, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -2.86 in one year’s time.
Technical Analysis of MBX Biosciences Inc (MBX)
MBX Biosciences Inc (NASDAQ: MBX) saw its 5-day average volume 0.59 million, a positive change from its year-to-date volume of 0.31 million. As of the previous 9 days, the stock’s Stochastic %D was 60.70%.
During the past 100 days, MBX Biosciences Inc’s (MBX) raw stochastic average was set at 87.85%, which indicates a significant increase from 69.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.55 in the past 14 days, which was higher than the 1.07 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.98, while its 200-day Moving Average is $13.82. Nevertheless, the first resistance level for the watch stands at $16.22 in the near term. At $17.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $19.81. If the price goes on to break the first support level at $12.62, it is likely to go to the next support level at $10.68. The third support level lies at $9.03 if the price breaches the second support level.
MBX Biosciences Inc (NASDAQ: MBX) Key Stats
There are 33,424K outstanding shares of the company, which has a market capitalization of 486.99 million. As of now, sales total 0 K while income totals -61,920 K. Its latest quarter income was 0 K while its last quarter net income were -23,880 K.
